Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 15;55(3):629–644. doi: 10.3892/ijo.2019.4839

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Han et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Immunostaining of the Piezo1 channel in human prostate carcinoma and paracarcinoma tissues. (A) Representative immunohistochemistry staining of Piezo1 (brown color). The right panel was extended from the square in left panel. (B) Summary data of Piezo1 channel expression in human prostate carcinoma (n=44) and paracarcinoma tissues (n=26). In comparison with paracarcinoma tissue (mean H-score 79.22±7.73), the prostate carcinoma tissue (mean H-score 142.90±5.22) showed a higher expression of Piezo1. (C) Piezo1 mRNA expression in patients with PRAD from the UALCAN database (normal, n=52; primary tumor, n=497; P=1.62448×10⁻¹²). Data are shown as the mean ± standard error of the mean. ^**P<0.01. PRAD, prostate adenocarcinoma; Piezo1, piezo type mechanosensitive ion channel component 1; TCGA, The Cancer Genome Atlas.